CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jason, J.
Right arrow Articles by Jarvis, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jason, J.
Right arrow Articles by Jarvis, W. R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 1999, p. 73-78, Vol. 6, No. 1
1071-412X/99/$00.00+0

Immune Determinants of Organism and Outcome in Febrile Hospitalized Thai Patients with Bloodstream Infections

Janine Jason,1,* Lennox Archibald,2 L. Clifford McDonald,2 W. Michael Hart,1 Sunthorn Rheanppumikankit,3 Somsit Tansuphwaswadikul,3 Martha G. Byrd,1 Joshua Larned,1,dagger Alison Han,1 Timothy A. Green,4 and William R. Jarvis2

Immunology Branch,1 and Office of the Director,4 Division of AIDS, Sexually Transmitted Diseases, and Tuberculosis Laboratory Research, and Investigation and Prevention Branch, Hospital Infections Program,2 National Center for Infectious Diseases Centers for Disease Control and Prevention, Public Health Service, Atlanta, Georgia 30333 and Bamrasnaradura Infectious Diseases Hospital, Nonthaburi, Thailand3

Received 1 May 1998/Returned for modification 13 August 1998/Accepted 2 October 1998

Opportunistic infections (OI) and the human immunodeficiency virus (HIV) cause significant morbidity and mortality in developing countries. Immune cell and cytokine profiles may be related to the type and course of OI and to the OI-HIV interaction. Examining cell-specific cytokine production ex vivo has only recently become feasible. In Thailand, 53 febrile, hospitalized adults were enrolled in a study of the immune correlates of bloodstream infections (BSI). On site, blood cells were stimulated ex vivo. Cell-surface antigens and eight intracellular cytokines were subsequently analyzed using flow cytometry to determine associations with mortality and the organism causing the BSI. By logistic regression analysis, the percentage of CD3+ CD16/56+ cells making tumor necrosis factor alpha (TNF-alpha ) (P = 0.033) and the percentage of CD3- CD16/56+ cells (NK) (P = 0.032) were related to HIV positivity. Lymph node enlargement with HIV infection and the percentage of CD3+ CD16/56+ making TNF-alpha were predictive of death. A lower percentage of CD3+ CD8+ lymphocytes making interleukin-8 (IL-8) (P = 0.005), fewer monocytes expressing CD14 (P = 0.009), and the percentage of CD3+ CD8+ cells producing gamma interferon (P = 0.011) were associated with blood culture positivity and the causative organism. For every one point decrease in the percentage of CD3+ CD8+ cells making IL-8, the likelihood of a positive culture increased 23%; for every one point decrease in the percentage of monocytes expressing CD14, the likelihood of a positive culture increased by 5%. Only a few immune cell types and three of their related cytokines were significantly associated with HIV disease outcome or the BSI organism. These cell types did not include CD3+ CD8- cells (a surrogate for CD4+ cells), nor did they involve cytokines associated with a type I to type II cytokine shift, which might occur with advancing HIV infection. These associations support the premise that CD8+ and CD16/56+ lymphocytes play significant roles in HIV and type I infections.


* Corresponding author. Mailing address: Mailstop A-25, Immunology Branch, DASTLR, NCID, CDC, 1600 Clifton Rd., N.E.; Atlanta, GA 30333. Phone: (404) 639-3919. Fax: (404) 639-2108. E-mail: JMJ1{at}CDC.gov.

dagger Present address: Tufts University, Medford, MA.


Clinical and Diagnostic Laboratory Immunology, January 1999, p. 73-78, Vol. 6, No. 1
1071-412X/99/$00.00+0



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 1999 by the American Society for Microbiology. All rights reserved.